To study variables associated with LVEF recovery in patients treated with sacubitril/valsartan (SV) in clinical practice
Latest Information Update: 22 Oct 2020
Price :
$35 *
At a glance
- Drugs Sacubitril/valsartan (Primary)
- Indications Heart failure
- Focus Therapeutic Use
- 22 Oct 2020 New trial record